INS and diabetes mellitus: RSG is a prototype of the TZD chemical class developed for the treatment of type 2 diabetes mellitus, and some of these effects are known to be mediated via gene transcriptional regulation [14–17]; however, the relationship between the RSG-mediated gene expression regulation in insulin-dependent tissues and the subsequent physiological changes remains unclear.